Latest filing published 03 Jun 2026 for Bionano Genomics, Inc., €30. Read the official filing
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Mark Oldakowski is a declared insider of Bionano Genomics, Inc. (chief executive), with filings sourced from SEC (Form 4). Between 12 May 2021 and 3 June 2026, the trades on record add up to 14 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
Most recently, on 3 June 2026, the filings show a share grant worth €30 in Bionano Genomics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations